AU2004291376A1 - Novel method of preparing 3-fluorinated quinolines - Google Patents
Novel method of preparing 3-fluorinated quinolines Download PDFInfo
- Publication number
- AU2004291376A1 AU2004291376A1 AU2004291376A AU2004291376A AU2004291376A1 AU 2004291376 A1 AU2004291376 A1 AU 2004291376A1 AU 2004291376 A AU2004291376 A AU 2004291376A AU 2004291376 A AU2004291376 A AU 2004291376A AU 2004291376 A1 AU2004291376 A1 AU 2004291376A1
- Authority
- AU
- Australia
- Prior art keywords
- fluoro
- methoxyquinoline
- formula
- temperature
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/44—Palladium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
Preparation of 3-fluoro-quinolines (I) (optionally substituted in the 5-, 6-, 7- and/or 8-position) involves heating a corresponding quinoline-3-diazonium tetrafluoroborate (II) in an inert organic solvent. Preparation of 3-fluoro-quinolines of formula (I) involves heating a quinoline-3-diazonium tetrafluoroborate of formula (II) in an inert organic solvent. [Image] R 1 - R 4H or F; linear, branched or cyclic alkyl (optionally substituted by 1-3 F, by OR 5 or by NR'R''); OR 6, NR' 1R'' 1 or COOR a; or phenyl or heteroaryl, both optionally substituted by one or more of the substituents given above or below; R 5H, alkyl or hydroxy-protecting group; R', R'' : H, alkyl or amino-protecting group; R 6H, phenol protecting group or alkyl (optionally substituted by 1-3 F, by OR 5 or by NR'R''); R' 1, R'' 1as for R', R''; or alkyl substituted by 1-3 F, by OR 5 or by NR'R''; and R aH, alkyl or carboxy-protecting group. An independent claim is included for (II) as new compounds.
Description
PUBLISHED SPECIFICATION VERIFICATION OF TRANSLATION Michael Bevan Robinson '........... ... I .. ...... I ..................... ,..... ... (insert translator's name) Of Cabinet Hirsch & Associ6s, 58 avenue Marceau, 75008 Paris, France ... ,o ... ... I, .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..... ° . . °... .... ... . ......... ......... .................. ............................................... °*.*****,,' " ********.,'*********.,.....*********,,, (translator's address) declare as follows: 1. That I am well acquainted with both the English and French languages, and 2. That the attached document is a true and correct translation made by me to the best of my knowledge and belief of.
(a) The specification of International Bureau pamphlet numbered WO 2005/049575 International Application No. PCT/FR2004/002 910 ... .. ... ... .............. ............... ... ...... . .. ....... (Date) (Signature of Traslator (No witness required) [R:\Libpal]Translators Verfication Cert for Published PCT.doc:STL 23680 PCGB 1 Novel method of preparing 3-fluorinated quinolines The invention relates to a novel process for preparing 5 3-fluoroquinolines of general formula (I): Ri R2 F
R
3 R4 in which R 1 , R 2 , R 3 and R 4 , which may be identical or different, represent: 10 - a fluorine atom; - a linear, branched or cyclic alkyl radical optionally substituted with one to three fluorine atoms, with a group ORs in which Rs represents a linear or branched alkyl radical, a hydrogen atom or a hydroxyl radical 15 protecting group, or with a group NR'R" in which R' and R", which may identical or different, represent a linear or branched alkyl radical, a hydrogen atom or an amino radical-protecting group; - a group OR 6 in which R 6 represents a hydrogen atom, a 20 phenol-protecting group or a linear or branched alkyl radical optionally substituted with one to three fluorine atoms, with ORs or with NR'R" as defined above; - a group NR'IR"I in which R' 1 and R"I have the values of R' and R" or represent a linear or branched alkyl radical 25 substituted with one to three fluorine atoms, with a group ORs as defined above or with a group NR'R" as defined above; - a group CO 2 Ra, in which Ra represents a hydrogen atom, a linear or branched alkyl radical or a carboxyl radical 30 protecting group; - a phenyl radical or a heteroaryl radical, optionally 23680 PCGB 2 substituted with one or more of the substituents mentioned above. In the general formula above, it is understood that the alkyl radicals contain 1 to 10 carbon atoms in a linear or 5 branched chain and that the cycloalkyl radicals contain 3 to 6 carbon atoms. When the compounds bear a heteroaryl substituent, the latter contains 5 to 10 ring members and may be monocyclic or bicyclic and chosen (in a nonlimiting manner), from thienyl, 10 furyl, pyrrolyl, imidazolyl, thiazolyl, oxazolyl, thiadiazolyl, oxadiazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrazinyl, pyrimidinyl, indolyl, benzothienyl, benzofuranyl, indazolyl, benzothiazolyl, naphthyridinyl, quinolyl, isoquinolyl, cinnolyl, quinazolyl, quinoxalyl, benzoxazolyl 15 and benzimidazolyl, which may be optionally substituted with the substituents stated above. According to the invention, the products of general formula (I) are obtained by a process wherein a compound of general formula (IV) Ri 0 R2 % II 2C-NH2 R3 (IV) R4 20 in which RI, R 2 , R 3 and R 4 are as defined hereinabove, is subjected to a Hofmann degradation, so as to obtain a compound of general formula (III) 23680 PCGB 3 Ri R2
NH
2
R
3 (I) R4 in which R 1 , R 2 , R 3 and R 4 are as defined hereinabove, which is treated under conditions capable of forming the diazonium salt of general formula (II) Ri R2
N
2
BF
4
R
3 () R4 5 in which R 1 , R 2 , R 3 and R 4 are as defined hereinabove, which is heated in an inert organic solvent to a temperature of between 35 and 120 0 C. The Hofmann degradation is carried out with bromine and 10 sodium hydroxide, and also pyridine, in water, at a temperature of approximately 60 0 C. The conditions for preparing the diazonium salt consist, for example, in carrying out the process in the presence of an alkali metal salt or of an ester of nitrous acid, in 15 particular of sodium nitrite or of potassium nitrite or of tert-butyl or isobutyl nitrite, and of fluoroboric acid, or in the presence of boron trifluoride-ethyl ether complex, in an appropriate solvent, in particular THF, water or an alcohol, at a temperature between +15 and +20 0 C. 20 In order to convert the compound of formula (II) to a compound of formula (I), the process is preferably carried out in a solvent such as toluene, xylene, heptane, hexane, a fluorinated solvent such as perfluorohexane, or else a 23680 PCGB 4 chlorinated solvent such as mono- or dichlorobenzene, chlorobutane or methylene chloride. The heating temperature is preferably between 60 and 100 0 C and depends, of course, on the solvent used. 5 A subject of the invention is also a process according to the above, wherein the compound of general formula (IV) is obtained by subjecting a compound of formula (V)
R
I X R2 CO 2 alk R3 N R4 (V) in which R 1 , R 2 , R 3 and R 4 are as defined hereinabove, X 10 represents a chlorine atom or a bromine atom and alk represents an alkyl radical containing from 1 to 6 carbon atoms, to the action of a hydrogenolysis agent, and then to that of aqueous ammonia, so as to obtain successively the compound of formula (VI) Ri
R
2
CO
2 alk
R
3 N (VI) R3 " R4 15 which may or may not be isolated, and then the compound of formula (IV). According to the invention, the two reactions above may be carried out in the reverse order, the compound 20 intermediately formed, and which may or may not be isolated, then being the compound of formula (VII) 23680 PCGB 5 R, X R2 CONH2 R3N R4 (VII) The hydrogenolysis reaction is carried out in an alcohol, in particular ethanol or methanol, in the presence of triethylamine and of a catalyst such as palladium-on 5 charcoal, by sparging hydrogen into the reaction medium. It is also possible to carry out the process in dimethylformamide, in the presence of sodium formate and of tetrakis(triphenylphosphine)palladium. A subject of the invention is also a process according 10 to the above, wherein the compound of formula (V) is obtained by subjecting a compound of formula (VIII) Ri OH 2
CO
2 alk R3 N (VIII) R4 in which R 1 , R 2 , R 3 and R 4 and alk are as defined hereinabove, to the action of phosphorus oxychloride or phosphorus 15 oxybromide. The process is preferably carried out without a solvent, at a temperature in the order of about 100 0 C. A subject of the invention is also a process according to the above, wherein the compound of formula (IV) is 20 obtained by treating a compound of formula (VIII), as defined above, with a base, so as to obtain a corresponding acid of formula (IX) 23680 PCGB 6 Ri OH 2 COOH
R
3 N (IX) R4 in which R 1 , R 2 , R 3 and R 4 are as defined hereinabove, which is subjected to the action of phosphorus oxychloride or of phosphorus oxybromide, so as to obtain a compound of formula 5 (K) Ri X R2 COX
R
3 N (x) R4 in which R 1 , R 2 , R 3 , R 4 and X are as defined hereinabove, which is subjected to the action of ammonia so as to obtain a compound of formula (VII) as defined above, which is 10 subjected to the action of a hydrogenolysis agent. The saponification reaction is carried out under conventional conditions known to those skilled in the art, in particular by the action of sodium hydroxide or potassium hydroxide in aqueous medium at reflux temperature. 15 The action of the phosphorus oxychloride or the phosphorus oxybromide is preferably carried out at the reflux temperature thereof, without solvent. The hydrogenolysis agent is one of those which were mentioned above. 20 A subject of the invention is also a process according to the above, wherein the compound of formula (IV) is obtained by heating a compound of formula (XI) 23680 PCGB 7 Ri
R
2 alkO 2 C CO 2 alk S IN I R '4 N (X I) R4 H in which Ra, R 2 , R 3 , R 4 and alk are as defined hereinabove, in the presence of phosphorus pentoxide, so as to obtain a compound of formula (IX) as defined above, and then pursuing 5 the synthesis as described above. The reaction of the phosphorus pentoxide with the compound of formula (XI) is preferably carried out in a solvent such as nitrobenzene at a temperature in the order of about 120-130 0 C. 10 The compound of formula (V) may also be obtained by subjecting a compound of formula (XI) as defined above to the action of phosphorus oxychloride or of phosphorus oxybromide. The process is preferably carried out without solvent, at a temperature in the order of about 100 0 C, starting with a 15 compound of formula (XI) in which the sensitive groups on RI,
R
2 , R 3 and R 4 are pre-protected. The compound of formula (VIII) may be obtained by heating a compound of formula (XI) as defined above, in a solvent with a high boiling point. 20 The cyclization of the compound of formula (XI) is preferably carried out in diphenyl ether, at reflux temperature or at a temperature similar to the reflux of the latter. The compound of general formula (XI) is obtained by 25 reacting a compound of general formula (XII) 23680 PCGB* 8 Ri R2
R
3
NH
2 (XII) R4 in which R 1 , R 2 , R 3 and R 4 are as defined hereinabove, with a compound of general formula (XIII) alkO 2 C CO 2 alk C H(XIll) Oalk 1 5 in which alk is as defined hereinabove and alk, represents a linear or branched alkyl radical which may be.identical or different to alk. Under preferential conditions, the reaction is carried out without the addition of a solvent, by heating to a 10 temperature of from about 80 to about 1200C. According to the definitions of R 1 , R 2 , R 3 and R 4 , it may be desirable, or even necessary, depending on the type of reaction involved, to use compounds in which the substituents are protected. These are in particular the alkyl 15 substituents substituted with ORs or with NR'R", OR 6 , NR' 1 iR"I and CO 2 Ra. A subject of the invention is in particular a process as defined above, wherein use is made of compounds in which the possible sensitive substituents are protected, during the 20 preparation of the compounds of formula (X) from the compounds of formula (IX) and also during the Hofmann degradation producing the compounds of formula (III) from the 23680 PCGB 9 compounds of formula (IV). According to the invention, the compounds involved are either protected from the beginning of synthesis or just before the critical step is carried out. The protective groups which may be used and also the use 5 thereof are known to those skilled in the art and described, for example, by T.W. Greene and P.G.M. Nuts, "Protective Groups in Organic Synthesis" (John Wiley & Sons, inc.). A subject of the invention is in particular a process according to the above, wherein use is made of compounds in 10 which RI, R 2 , R 3 and R 4 , which may be identical or different, represent a hydrogen atom, a fluorine atom, an optionally substituted linear or branched alkyl radical as defined above, or a radical OR 6 as defined above. The subject of the invention is more particularly a 15 process wherein use is made of compounds in which RI, R 2 , R 3 and R 4 , which may be identical or different, represent a hydrogen atom, a fluorine atom or a radical OR 6 as defined above, and in particular an alkoxy radical. Finally, a subject of the invention is a compound of 20 formula (II) as defined above. The compounds of formula (I) are intermediate compounds useful in particular in the preparation of compounds having antibacterial activity, described, for example, in applications WO 02/72572 and WO 02/40474. 25 The following examples illustrate the invention without, however, limiting it. Example 1: Preparation of 3-fluoro-6-methoxyquinoline: A suspension of 1007 g of 6-methoxy-3-quinolinediazonium 30 fluoroborate taken in 9 1 of toluene is heated to 60 0 C in 85 minutes. A release of gas is observed at 60 0 C. The reaction medium is then gradually heated further for 90 minutes to 70-72 0 C. After having been kept at 72 0 C for 90 minutes, the medium is then gradually heated again to 85 0 C. 35 After cooling and stirring overnight, 4 1 of ice-cold water are added to the suspension. After having stirred for 15 minutes, 2.5 1 of ethyl acetate are added. After having stirred for 45 minutes, the pH is adjusted to pH = 7-7.5 by 23680 PCGB 10 adding 47% sodium hydroxide (250 ml). The medium is stirred for 30 minutes and then separated by settling out for 1 hour. The lower aqueous phase is re-extracted with ethyl acetate. The organic phases are combined together and washed with 5 water. The solution is filtered and then concentrated under reduced pressure so as to give 655 g of crude 3-fluoro 6-methoxyquinoline. The crude product is distilled under reduced pressure. The distillation fractions (bp 103-110 0 C under 1 mbar) containing the expected product are combined 10 together. 498.9 g of 3-fluoro-6-methoxyquinoline (76%) are thus obtained in the form of a white solid which melts at 51-53oC. Microanalysis: CIoH 8 FNO calculated C 67.79; H 4.55; F 10.72; 15 N 7.91; O 9.03 found C 67.98; H 4.54; N 7.97 NMR spectrum: 1 H (300 MHz, (CD 3
)
2 SO d6, 6 in ppm) : 3.92 (s: 3H); 7.40 (mt: 2H); 7.97 (d, J = 10 Hz: 1H); 8.13 (dd, J = 10 and 3 Hz: 1H); 8.76 (d, J = 3 Hz: 1H). 20 Mass spectrum: m = 177 El m/z = 177 M- base peak m/z = 134 [M - COCH 3 ]+ 25 DCI m/z = 178 MH base peak 3-Diazoniumfluoroborate-6-methoxyguinoline: 3-Amino-6-methoxyquinoline (10 g) are suspended in 50 ml of THF and stirred for 15 minutes at 20 0 C, before being cooled 30 to -150C. 11.6 g of BF 3 -etherate are then added. The temperature of the reaction mass is brought to -15 0 C. After 15 minutes at this temperature, 7.5 g of tert-butyl nitrite at 90% in solution in 25 ml of THF are added over 10 minutes. The suspension is stirred for 1 hour at -15 0 C, before being 35 brought to +15 0 C over a period of one hour. The precipitate is filtered off, washed with hexane and then dried at 15-20 0 C under constant pressure until a constant weight is obtained.
23680 PCGB 11 14.8 g (94.3%) of 3-diazoniumfluoroborate-6-methoxyquinoline are obtained in the form of a yellow solid. Decomposition temperature: 82 0 C 5 3-Amino-6-methoxyguinoline: 104 kg of a 32% sodium hydroxide solution are added to 341 kg of water. The solution is cooled to 0 0 C and 22.0 kg of bromine are introduced over 1.5 hours while maintaining the temperature at 0 0 C. The solution is stirred at this 10 temperature for 1 hour, and then 409 kg of pyridine are introduced over 3 hours at 0 0 C. 26.5 kg of 6-methoxy quinoline-3-carboxamide are then added over 50 minutes at 0 0 C. The reaction medium is kept at this temperature for 2 hours and then gradually heated to 60 0 C over 1 hour. After 15 maintaining the temperature at 60 0 C for 6 hours, the reaction mass is cooled to 200C and separated by settling out. The aqueous phase (172 kg) is washed with.pyridine (60 liters). The organic phases are pooled (820 kg) and concentrated to dryness under reduced pressure (100-150 mbar) at a maximum of 20 84oC. The residue is then taken up with 425 1 of water and 43 1 of ethanol. The suspension obtained is refluxed for 1 hour and then cooled. The product begins to precipitate at a temperature of 650C. The medium is then cooled to 0-50C, and kept at this temperature for 2 hours. The precipitate is 25 filtered off, washed with cold water, and then dried at 50-55 0 C under reduced pressure. 16.5 kg (72.3%) of 3-amino 6-methoxyquinoline are obtained in the form of a brown solid (HPLC titer = 99.1%), having a melting point of 108-1100C. A second crop of 3.7 kg (13.1%) is obtained from the mother 30 liquors (HPLC titer = 98%). NMR spectrum: 1H (300 MHz, (CD 3
)
2 S0 d6, 6 in ppm): 3.84 (s: 3H); 5.65 (s: 2H); 6.97 (dd, J = 9 and 3 Hz: 1H); 7.01 (d, J = 3 Hz: 1H); 7.08 (d, J = 2.5 Hz: 1H); 7.67 (d, J = 9 Hz: 35 1H); 8.29 (d, J = 2.5 Hz: 1H).
23680 PCGB 12 IR spectrum: (KBr) 3454; 3312; 3204; 1630; 1619; 1607; 1504; 1383; 1251; 1239; 1216; 1167; 1027; 872; 827; 627 and 479 cm 5 Mass spectrum: m = 174 El m/z = 174 (M ) - base peak m/z = 131 [M - COCH 3 ] . 6-Methoxyguinoline-3-carboxamide: 380 1 of ethanol are added to 49.2 kg of 4-chloro-3-ethoxy 10 carbonyl-6-methoxyquinoline. The suspension is heated at 45 0 C for 30 minutes and then cooled to 200C. 18.65 kg of triethylamine are added under nitrogen, followed by 1.91 kg of palladium-on-charcoal at 5% (at 60% water content). A stream of hydrogen is passed through under 0.5-0.8 bar at 15 33oC for 48 hours. At this time, an HPLC' control shows that the reaction is complete. The reactor is then vented with nitrogen land the reaction medium is then filtered to remove the catalyst. The filter is then rinsed with ethanol. The filtrate is poured over 750 kg of an aqueous ammonia 20 solution. The reaction medium is then stirred at 25 0 C over a period of 4 days. The ethanol is then removed by distillation under reduced pressure at a temperature not exceeding 40-450C. The suspension thus obtained is cooled to 0-5 0 C and stirred for 3 hours at this temperature. The 25 precipitate is filtered off, washed with cold water, and then dried at 60-65 0 C under reduced pressure until a constant weight is obtained. 26.5 kg (71%) of 6-methoxyquinoline-3 carboxamide are obtained in the form of a white solid which melts at 93.7-95.7C (HPLCNIs= 98.3%). 30 NMR spectrum: 1 H (300 MHz, (CD 3
)
2 S0 d6, 6 in ppm): 3.94 (s: 3H); 7.45 (d, J = 3 Hz: 1H); 7.52 (dd, J = 9 and 3 Hz: 1H); 7.67 (broad s: 1H); 8.00 (d, J = 9 Hz: 1H); 8.29 (broad s: 1H); 8.74 (d, J = 2 Hz: 1H); 9.15 (d, J = 2 Hz: 1H). 35 IR spectrum: (KBr) 3408; 3330; 3211; 1697; 1626; 1511; 1386; 1321; 1240; 1023; 935; 826 and 693 cm
"
23680 PCGB 13 Mass spectrum: m = 202 El m/z = 202 [M' ] - base peak m/z = 186 [M -NH 2 ] m/z = 158 [186 - CO] + 5 4-Chloro-3-ethoxycarbonyl-6-methoxyquinoline: 132 g of phosphoryl chloride are added, at 25 0 C, to 50 g of diethyl 2-[(4-methoxyphenylamino)methylene]malonate. The reaction medium is stirred for 15 minutes at this 10 temperature, heated to 95-100 0 C over 45 minutes, and then kept at this temperature for 4 hours. The excess phosphoryl chloride is then removed by heating at 125 0 C for approximately 2 hours. The mixture is then cooled to 25 0 C and 125 ml of dichloromethane are added. The medium is then 15 stirred at 25 0 C for 1 hour, and then run into 900 ml of water, over 30 minutes, while maintaining the temperature below.30 0 C. The pH is then adjusted to 7.5-8 by adding 172 g of. a 47% sodium hydroxide solution, while maintaining the temperature at 20-25 0 C. The 2 phases are separated and the 20 aqueous phase is extracted with dichloromethane. The organic phases are pooled and washed with water. The dichloromethane phase is half-concentrated and 190 ml of ethanol are added. The concentration is continued until the temperature of the reaction mass reaches 82 0 C and the vapor temperature reaches 25 78 0 C. The reaction mass is cooled to 0-50C and then kept at this temperature for 2 hours. The precipitate is filtered off, washed with cold ethanol, and then dried at 50 0 C under reduced pressure. 27.7 g (61%) of 4-chloro-3-ethoxycarbonyl 6-methoxyquinoline are obtained in the form of a yellow solid 30 which melts at 93.7-95.7 0 C. Titer (HPLC): 98.0% Diethyl 2-[(4-methoxyphenylamino)methylene]malonate: 35 3.5 kg of p-anisidine are added to 6.25 kg of diethyl ethoxymethylenemalonate at 14oC, over 85 minutes without cooling of the reaction mass. At the end of addition, the temperature has reached 59WC. The temperature is kept at 23680 PCGB 14 59 0 C for 30 minutes, and the reaction medium is then heated to 90-95oC and kept at this temperature for 1 hour. The ethanol formed is then removed by distillation at atmospheric pressure and then under 250 mbar. After cooling to 45 0 C, 5 8.4 kg of diethyl 2- [(4-methoxyphenylamino)methylene]malonate are recovered in the form of a brown viscous oil, with a quantitative yield. Titer (HPLC): 98.3% 10 References: 1/ Description of the analytical conditions: Method: HPLC 15 Column: Hichrom 100 RPl8 5 p (250 x 4.6 mm) Flow rate: 1 ml/min Wavelength: 210 nm Injection volume: 20 ipl 20 Eluent: 400 ml acetonitrile 600 ml 0.01M sodium dihydrogen phosphate (pH 2.3) 2.88 gil/1 sodium dodecyl sulfate. Injection: 20 pl of 0.1 mg/ml solution. 25 Retention time: p-anisidine 12.16 min 2-[(4-methoxyphenylamino)methylene]malonic acid diethyl ester 25.0 min 30 3-ethoxycarbonyl-6-methoxy-4 (lH)-quinolinone 4.15 min 4 -chloro-6-methoxyquinoline-3-ethyl carboxylate 24.1 min 6-methoxyquinoline-3-ethyl carboxylate 16.5 min 6-methoxyquinoline-3-carboxamide 6.0 min 3-amino-6-methoxyquinoline 16.2 min 35 3 -fluoro-6-methoxyquinoline 10.0 min 23680 PCGB 15 Example 2: 3,7-Difluoro-6-methoxyquinoline 6.1 g of 3-amino-7-fluoro-6-methoxyquinoline are added, with stirring at a temperature in the region of -5 0 C, to an aqueous 40% fluoroboric acid solution, and a solution of 5 2.6 g of sodium nitrite in 5.2 cm 3 of water is then added over 20 minutes. The reaction mixture is stirred at a temperature in the region of +3 0 C for 40 minutes, and then filtered. The solid is washed with an aqueous 40% fluoroboric acid solution at -5 0 C, then with a mixture of isopropanol and of an aqueous 10 40% fluoroboric acid solution at -50C, and then with ethyl ether, spin-filtered to dryness and dried under reduced pressure. 9.95 g of a solid are thus obtained, which are dissolved in 80 cm 3 of anhydrous toluene, and this solution is brought to 92 0 C for 1 hour with vigorous stirring. After 15 cooling to ambient temperature, 50 cm 3 of toluene are added, followed by 80 cm 3 of a saturated aqueous solution of sodium hydrogen carbonate. The reaction medium is separated by settling out, the aqueous phase is extracted with toluene, and the organic phases are pooled, washed with a saturated 20 aqueous solution of sodium chloride, and then dried over sodium sulfate. After filtration and then evaporation to dryness under reduced pressure of the toluene, the residue is chromatographed on a silica column (100 g, particle size 20-46 pm, eluent: dichloromethane). The fractions containing 25 the expected product are evaporated to dryness under reduced pressure. 2.28 g of 3,7-difluoro-6-methoxyquinoline are obtained, in the form of a white solid which melts at 980C. 3-Amino-7-fluoro-6-methoxyquinoline: 30 2.4 cm of bromine are added dropwise, over 30 minutes, to a solution of 133 cm 3 of aqueous 2N sodium hydroxide solution cooled to 0 0 C, followed by 111 cm 3 of pyridine. 10.1 g of 7-fluoro-6-methoxyquinoline-3-carboxamide are then added to this solution, still at 0OC, and the mixture is stirred at 35 0OC for 2 hours 30 min. The reaction medium is then allowed to warm back up to ambient temperature, and is then heated with stirring to 600C for 18 h. It is then allowed to cool down again to ambient temperature, and 100 cm 3 of water, 23680 PCGB 16 followed by 100 cm of ethyl acetate, are then added. The reaction medium is separated by settling out, the aqueous phase is extracted with ethyl acetate, and the aqueous phases are pooled, washed with water and then dried over sodium 5 sulfate and evaporated to dryness under reduced pressure. 8.25 g of a solid residue are obtained, which residue is triturated in 150 cm 3 of isopropyl ether and filtered. The solid is washed with isopropyl ether and then with pentane. After drying, 6.20 g of 3-amino-7-fluoro-6-methoxyquinoline 10 are obtained, in the form of a light brown solid which melts at 1530C. 7-Fluoro-6-methoxyguinoline-3-carboxamide: 5.58 g of sodium formate and 3.16 g of tetrakis 15 (triphenylphosphine)palladium are added to a solution of 13..9 g of 4-chloro-7-fluoro-6-methoxyquinoline-3-carboxamide in 278 cm 3 of dimethylformamide, and this solution is heated under an argon atmosphere at 1000C for 5 hours. After cooling to ambient temperature, the reaction medium is 20 filtered. The filtrate is concentrated under reduced pressure so as to obtain 200 cm 3 of a solution, to which 600 cm 3 of water are added. The precipitate formed is filtered off, washed with water and then dried at 50 0 C under reduced pressure. The solid obtained is washed with toluene, then 25 twice with ethyl ether, and then with pentane. 10.7 g of 7 fluoro-6-methoxyquinoline-3-carboxamide are obtained, in the form of a beige solid which melts at 231oC. 4-Chloro-7-fluoro-6-methoxyquinoline-3-carboxamide: 30 A stirred solution of 15.83 g of 7-fluoro-4-hydroxy-6 methoxyquinoline-3-carboxylic acid in 40 cm 3 of phosphoryl chloride is brought to 1000C for 3 hours. After cooling to ambient temperature, the reaction medium is distilled under atmospheric pressure in order to remove the phosphoryl 35 chloride. The residue is dissolved in 70 cm 3 of dichloromethane, and then ammonia is sparged into this solution, which is kept at 250C with stirring for 5 hours. The reaction medium is then filtered, and the solid obtained 23680 PCGB 17 is washed with dichloromethane and then dried at 50 0 C under reduced pressure. 14.05 g of 4-chloro-7-fluoro-6-methoxy quinoline-3-carboxamide are obtained, in the form of an off white solid which melts at 228 0 C. 5 7-Fluoro-4-hydroxy-6-methoxyquinoline-3-carboxylic acid: A stirred solution of 23.57 g of ethyl 7-fluoro-4-hydroxy-6 methoxyquinoline-3-carboxylate in 71 cm 3 of an aqueous 5N sodium hydroxide solution is brought to 100 0 C for 3 hours. 10 After cooling to ambient temperature, the reaction medium is acidified by adding 32.5 cm 3 of an aqueous 37% hydrochloric acid solution. After addition of 150 cm 3 of water, the precipitate obtained is filtered off and the solid is washed with water. After drying in the open air, 22 g of 7-fluoro 15 4-hydroxy-6-methoxyquinoline-3-carboxylic acid are obtained, in the form of a cream solid which melts at 275 0 C. Ethyl 7-fluoro-4-hydroxy-6-methoxyquinoline-3-carboxylate: 20 A stirred solution of 37.75 g of diethyl 2-[(3-fluoro-4 methoxyphenylamino)methylene]malonate in 170 cm 3 of diphenyl ether is brought to 245 0 C for 3.5 hours. After cooling to ambient temperature, 220 cm 3 of cyclohexane are added, and the precipitate thus obtained is filtered off and washed with 25 cyclohexane and then with pentane and is spin-filtered to dryness. 24.10 g of ethyl 7-fluoro-4-hydroxy-6-methoxy quinoline-3-carboxylate are obtained, in the form of a solid which melts at 280 0 C. 30 Diethyl 2-[(3-fluoro-4-methoxyphenylamino)methylene]malonate: A stirred mixture of 15.61 g of 3-fluoro-4-methoxyaniline and of 24.25 g of diethyl ethoxymethylenemalonate is brought to 100 0 C for 2.5 hours. After cooling to ambient temperature and then evaporation to dryness at 50 0 C under reduced 35 pressure, 35 g of diethyl 2-[(3-fluoro-4 methoxyphenylamino)methylene]malonate are obtained, in the form of a beige solid which melts at 63 0
C.
23680 PCGB 18 Example 3: 3,8-Difluoro-6-methoxyquinoline By carrying out the process as described in Example 2, but using 2.35 g of 3-amino-8-fluoro-6-methoxyquinoline, 1.35 g of 3,8-difluoro-6-methoxyquinoline are obtained, in the form 5 of a white solid which melts at 122 0 C Characteristics of the synthesis intermediates: 3-Amino-8-fluoro-6-methoxyquinoline: brown solid which melts 10 at 135 0 C. 8-Fluoro-6-methoxyquinoline-3-carboxamide: beige solid which melts at 248 0 C. 15 4-Chloro-8-fluoro-6-methoxyquinoline-3-carboxamide: light brown solid which melts at 220 0 C. 8-Fluoro-4-hydroxy-6-methoxyquinoline-3-carboxylic acid: beige solid which melts at around 280 0 C. 20 Ethyl 8-fluoro-4-hydroxy-6-methoxyquinoline-3-carboxylate: light brown solid which melts at 221 0 C. Diethyl 2-[(2-fluoro-4-methoxyphenylamino)methylene]malonate: 25 mass spectrum El m/z = 311 (M ). 2-Fluoro-4-methoxyaniline is used at the start. Example 4: 3,6-Difluoroquinoline 30 By carrying out the process as described in Example 2, but using 3-amino-6-fluoroquinoline, 3,6-difluoroquinoline is obtained, mass spectrum El m/z = 165 (M ). Characteristics of the synthesis intermediates: 35 3-Amino-6-fluoroquinoline: mass spectrum El m/z = 162 (M).
23680 PCGB 19 6-Fluoroquinoline-3-carboxamide: mass spectrum El m/z = 190 (M+). 4-Chloro-6-fluoroquinoline-3-carboxamide: mass spectrum El 5 m/z = 224 (M ). 4-Hydroxy-6-fluoroquinoline-3-carboxylic acid: mass spectrum El m/z = 207 (M ). 10 Ethyl 4-hydroxy-6-fluoroquinoline-3-carboxylate: mass spectrum El m/z = 235 (M ). Diethyl 2-[(2-fluoro-4-methoxyphenylamino)methylene]malonate: mass spectrum El m/z = 281 (M ). 15 4-Fluoroaniline is used at the start.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0313384A FR2862301B1 (en) | 2003-11-17 | 2003-11-17 | NEW PROCESS FOR THE PREPARATION OF 3-FLUORINATED QUINOLINES |
FR0313384 | 2003-11-17 | ||
PCT/FR2004/002910 WO2005049575A1 (en) | 2003-11-17 | 2004-11-15 | Novel method of preparing 3-fluorinated quinolines |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2004291376A1 true AU2004291376A1 (en) | 2005-06-02 |
Family
ID=34508487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2004291376A Abandoned AU2004291376A1 (en) | 2003-11-17 | 2004-11-15 | Novel method of preparing 3-fluorinated quinolines |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1687276B1 (en) |
JP (1) | JP4751333B2 (en) |
KR (1) | KR20060123161A (en) |
CN (1) | CN100537540C (en) |
AT (1) | ATE445605T1 (en) |
AU (1) | AU2004291376A1 (en) |
CA (1) | CA2542796C (en) |
DE (1) | DE602004023640D1 (en) |
ES (1) | ES2334796T3 (en) |
FR (1) | FR2862301B1 (en) |
HK (1) | HK1099020A1 (en) |
HR (1) | HRP20060168A2 (en) |
IL (1) | IL175649A (en) |
IS (1) | IS8423A (en) |
MX (1) | MXPA06005599A (en) |
NO (1) | NO20062761L (en) |
RU (1) | RU2351591C2 (en) |
WO (1) | WO2005049575A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7396934B2 (en) | 2003-11-17 | 2008-07-08 | Youssef El-Ahmad | Process for preparing 3-fluoroquinolines |
US8716280B2 (en) | 2009-01-21 | 2014-05-06 | Basilea Pharmaceutica Ag | Bicyclic antibiotics |
CN104672131B (en) * | 2013-11-27 | 2017-03-15 | 中国科学院大连化学物理研究所 | A kind of method of 3 fluorine quinolines of synthesis |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA801526B (en) * | 1979-03-26 | 1981-08-26 | Robins Co Inc A H | 4-amino-3-quinolinecarboxylic acids and esters-antisecretory, anti-ulcer compounds |
DE3620856A1 (en) * | 1986-06-21 | 1987-12-23 | Basf Ag | 3-CYANCHINOLINE DERIVATIVES |
DK273689A (en) * | 1988-06-06 | 1989-12-07 | Sanofi Sa | 4-AMINO-3-CARBOXYQUINOLINES AND -NAPHTHYRIDINES, PROCEDURES FOR THEIR PREPARATION AND USE OF THEM IN PHARMACEUTICALS |
JPH06287187A (en) * | 1993-04-02 | 1994-10-11 | Nippon Soda Co Ltd | New pyrazole derivative and its abricultural and horticultural germicide |
SE0004056D0 (en) * | 2000-11-06 | 2000-11-06 | Astrazeneca Ab | N-type calcium channel antagonists for the treatment of pain |
FR2816618B1 (en) * | 2000-11-15 | 2002-12-27 | Aventis Pharma Sa | HETEROCYCLYLALCOYL PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM |
FR2822154B1 (en) * | 2001-03-13 | 2005-10-21 | Aventis Pharma Sa | QUINOLYL PROPYL PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM |
TWI275390B (en) * | 2002-04-30 | 2007-03-11 | Wyeth Corp | Process for the preparation of 7-substituted-3- quinolinecarbonitriles |
-
2003
- 2003-11-17 FR FR0313384A patent/FR2862301B1/en not_active Expired - Fee Related
-
2004
- 2004-11-15 RU RU2006120275/04A patent/RU2351591C2/en not_active IP Right Cessation
- 2004-11-15 CN CNB2004800337575A patent/CN100537540C/en not_active Expired - Fee Related
- 2004-11-15 AU AU2004291376A patent/AU2004291376A1/en not_active Abandoned
- 2004-11-15 AT AT04805450T patent/ATE445605T1/en not_active IP Right Cessation
- 2004-11-15 WO PCT/FR2004/002910 patent/WO2005049575A1/en active Application Filing
- 2004-11-15 EP EP04805450A patent/EP1687276B1/en not_active Expired - Lifetime
- 2004-11-15 DE DE602004023640T patent/DE602004023640D1/en not_active Expired - Lifetime
- 2004-11-15 KR KR1020067009538A patent/KR20060123161A/en not_active Application Discontinuation
- 2004-11-15 JP JP2006538900A patent/JP4751333B2/en not_active Expired - Fee Related
- 2004-11-15 CA CA2542796A patent/CA2542796C/en not_active Expired - Fee Related
- 2004-11-15 ES ES04805450T patent/ES2334796T3/en not_active Expired - Lifetime
- 2004-11-15 MX MXPA06005599A patent/MXPA06005599A/en active IP Right Grant
-
2006
- 2006-04-21 IS IS8423A patent/IS8423A/en unknown
- 2006-05-09 HR HR20060168A patent/HRP20060168A2/en not_active Application Discontinuation
- 2006-05-15 IL IL175649A patent/IL175649A/en not_active IP Right Cessation
- 2006-06-13 NO NO20062761A patent/NO20062761L/en not_active Application Discontinuation
-
2007
- 2007-06-16 HK HK07106501.2A patent/HK1099020A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP4751333B2 (en) | 2011-08-17 |
EP1687276B1 (en) | 2009-10-14 |
DE602004023640D1 (en) | 2009-11-26 |
FR2862301A1 (en) | 2005-05-20 |
ES2334796T3 (en) | 2010-03-16 |
WO2005049575A1 (en) | 2005-06-02 |
CA2542796C (en) | 2011-08-02 |
FR2862301B1 (en) | 2007-12-21 |
HK1099020A1 (en) | 2007-08-03 |
ATE445605T1 (en) | 2009-10-15 |
EP1687276A1 (en) | 2006-08-09 |
IL175649A (en) | 2011-01-31 |
RU2351591C2 (en) | 2009-04-10 |
NO20062761L (en) | 2006-08-17 |
MXPA06005599A (en) | 2007-01-26 |
CA2542796A1 (en) | 2005-06-02 |
IL175649A0 (en) | 2006-09-05 |
RU2006120275A (en) | 2008-01-10 |
JP2007511490A (en) | 2007-05-10 |
CN100537540C (en) | 2009-09-09 |
HRP20060168A2 (en) | 2006-09-30 |
IS8423A (en) | 2006-04-21 |
KR20060123161A (en) | 2006-12-01 |
CN1894216A (en) | 2007-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR0162897B1 (en) | Method for preparing 1H-imidazo (4,5-C) quinoline | |
JP5881691B2 (en) | Process for producing quinoline-3-carboxamide | |
IE840443L (en) | Quinolonecarboxylic acids | |
AU2004291376A1 (en) | Novel method of preparing 3-fluorinated quinolines | |
WO1999014196A1 (en) | Method for the synthesis of quinoline derivatives | |
JPS63179856A (en) | Method for producing quinolone carboxylic acid derivatives and intermediates thereof | |
EP0990647A1 (en) | Process for producing quinolone derivatives | |
US7396934B2 (en) | Process for preparing 3-fluoroquinolines | |
EP1391455B1 (en) | Process for preparation of a quinolinecarbaldehyde | |
EP2217585A2 (en) | Process for the preparation of 2h-chromene-3-carbamate derivatives | |
US6841681B2 (en) | Process for producing quinoline carboxyaldehyde derivative and intermediate thereof | |
JPWO2010027060A1 (en) | Method for producing 3,5-dihydroxy-6-heptenoic acid amine salt | |
EP1282603A2 (en) | An improved process for the preparation of quinolone derivatives | |
FR2487346A1 (en) | 4-OXIMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES, PROCESS FOR PREPARING THEM AND THERAPEUTIC APPLICATION THEREOF | |
JPH11292873A (en) | Method for producing quinolone carboxylic acid derivative and intermediate thereof | |
CA2398138C (en) | Process for the preparation of quinolylpropenal | |
JP3022908B2 (en) | Process for producing 8-hydroxyquinolone carboxylic acid esters | |
KR100330141B1 (en) | Preparation of 6-fluoro-2-halogenquinoline | |
Deady | A synthesis of Benzo [c][1, 8] naphthyridinones: an exception to the Knorr reaction | |
FR2640974A1 (en) | ||
GB2279346A (en) | Benzofuran intermediates | |
JP2003514800A (en) | Method for producing N-substituted 2-pyrazolin-5-one | |
JPH0616628A (en) | Indole derivative | |
HU192584B (en) | Process for producing 4-quinolinones | |
JPS6123797B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |